AbbVie Submits Applications for Upadacitinib in Non-Radiographic Axial Spondyloarthritis to U.S. Food and Drug Administration and European Medicines Agency Pharmaceutical Investing
Lobe Sciences to Present At H.C. Wainwright BIOCONNECT Investment Conference Pharmaceutical Investing
Real World Evidence Shows Johnson & Johnson COVID-19 Vaccine Demonstrates Durable Protection Against Breakthrough Infection, Hospitalization, and Intensive Care Unit Admission in the United States Pharmaceutical Investing
BAUSCH HEALTH TO PARTICIPATE AT THE 40TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE Pharmaceutical Investing
Biohaven and Pfizer Complete Collaboration Transaction for Commercialization of Rimegepant and Zavegepant Outside United States Pharmaceutical Investing
Pfizer and BioNTech Sign New Global Collaboration Agreement to Develop First mRNA-based Shingles Vaccine Pharmaceutical Investing
Seegnal Inc. Establishes Strategic Commercialization Team and Appoints Arx as Investor Relations Advisor
